The Archive · 7 posts
Innovative chemistry at its best! 🌟 Synthomer PLC (SYNT) leads the way in specialty chemicals on the LSE. Discover more today! 🔍
Synthomer delivered stronger first-half trading and upgraded its outlook, but investors must weigh that progress against £671.3 million of net debt.
August 4, 2026
Showing 6 of 7 posts
Synthomer FY2025: margins up to 7.8%, free cash flow positive, net debt lower. Refinancing extends to 2029. Key takeaways from the chemicals group's results.
JoshuaApril 30, 2026
Synthomer confirms resilient 2025 earnings, positive cash flow & no equity raise planned. Focus now on constructive refinancing talks & asset sales to manage 2027 maturities.
JoshuaMarch 19, 2026
Synthomer's 2025 update shows resilient earnings, positive cash flow, and lower debt through margin improvement and cost savings in a tough market.
JoshuaJanuary 29, 2026
Synthomer taps major shareholder KLK for £50m receivables purchase to secure year-end covenant headroom in temporary, arms-length deal.
JoshuaDecember 18, 2025
Synthomer H1 EBITDA grows 5.4% despite revenue dip, as margin expansion and cost discipline drive strategic transformation amid market turbulence.
JoshuaAugust 5, 2025
Synthomer's Q1 2025 EBITDA growth driven by cost efficiencies & regional manufacturing strategy, resilient amid trade tensions and market uncertainty.
JoshuaMay 1, 2025
January 29, 2026